Cargando…
The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders
Antibodies to SOXB1 proteins in patients with paraneoplastic disorders are associated with small-cell lung cancer (SCLC), particularly in Lambert-Eaton myasthenic syndrome (LEMS). We aimed to establish if SOX2 antibodies could be used to identify SCLC and other tumours found in a range of paraneopla...
Autores principales: | Maddison, Paul, Titulaer, Maarten J., Verschuuren, Jan J., Gozzard, Paul, Lang, Bethan, Irani, Sarosh R., Sabater, Lidia, Graus, Francesc, Murray, Andrea, Chapman, Caroline J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375907/ https://www.ncbi.nlm.nih.gov/pubmed/30445363 http://dx.doi.org/10.1016/j.jneuroim.2018.11.003 |
Ejemplares similares
-
Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
por: Arnaldos-Pérez, Cristina, et al.
Publicado: (2023) -
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021) -
Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
por: Ruiz-García, Raquel, et al.
Publicado: (2019) -
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017) -
Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study
por: Gozzard, Paul, et al.
Publicado: (2015)